Novartis AG Goodwill and Intangible Assets 2010-2025 | NVS

Novartis AG goodwill and intangible assets for the quarter ending March 31, 2025 were $52.441B, a 6.3% increase year-over-year.

  • Novartis AG goodwill and intangible assets for 2024 were $51.671B, a 2.89% increase from 2023.
  • Novartis AG goodwill and intangible assets for 2023 were $50.22B, a 17.6% decline from 2022.
  • Novartis AG goodwill and intangible assets for 2022 were $60.945B, a 4.44% decline from 2021.

Novartis AG Goodwill and Intangible Assets 2010-2025 | NVS

  • Novartis AG goodwill and intangible assets for 2024 were $51.671B, a 2.89% increase from 2023.
  • Novartis AG goodwill and intangible assets for 2023 were $50.22B, a 17.6% decline from 2022.
  • Novartis AG goodwill and intangible assets for 2022 were $60.945B, a 4.44% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B